This company listing is no longer active
TBD Stock Overview
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Emerald Health Therapeutics, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.016 |
52 Week High | CA$0.071 |
52 Week Low | CA$0.014 |
Beta | 0.63 |
1 Month Change | 4.58% |
3 Month Change | -36.00% |
1 Year Change | -70.91% |
3 Year Change | -95.93% |
5 Year Change | -98.97% |
Change since IPO | -95.95% |
Recent News & Updates
Recent updates
Shareholder Returns
TBD | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 4.6% | -2.6% | -0.4% |
1Y | -70.9% | -27.1% | 5.0% |
Return vs Industry: TBD underperformed the German Pharmaceuticals industry which returned -13.3% over the past year.
Return vs Market: TBD underperformed the German Market which returned -21.8% over the past year.
Price Volatility
TBD volatility | |
---|---|
TBD Average Weekly Movement | 45.8% |
Pharmaceuticals Industry Average Movement | 6.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: TBD's share price has been volatile over the past 3 months.
Volatility Over Time: TBD's weekly volatility has increased from 39% to 46% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 111 | n/a | https://emeraldhealth.ca |
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015.
Emerald Health Therapeutics, Inc. Fundamentals Summary
TBD fundamental statistics | |
---|---|
Market cap | €5.44m |
Earnings (TTM) | -€20.52m |
Revenue (TTM) | €5.19m |
1.0x
P/S Ratio-0.3x
P/E RatioIs TBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TBD income statement (TTM) | |
---|---|
Revenue | CA$7.13m |
Cost of Revenue | CA$12.67m |
Gross Profit | -CA$5.54m |
Other Expenses | CA$22.64m |
Earnings | -CA$28.18m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.13 |
Gross Margin | -77.71% |
Net Profit Margin | -395.33% |
Debt/Equity Ratio | 0% |
How did TBD perform over the long term?
See historical performance and comparison